📑 Table of Contents
Proteon, Inc.
TypePublic
Nasdaq: PTON
IndustryNetworking equipment
Founded1972
Defunct1998
FateRelaunched as OpenROUTE Networks
SuccessorNetrix, NX Networks, NSGDatacom
HeadquartersWestborough, Massachusetts, Massachusetts, US,
Key people
Howard Salwen, Founder

Proteon, Inc. was a pioneering designer and manufacturer of computer network equipment based in Westborough, Massachusetts. Proteon created the first commercial Token Ring products and created the first commercially available multiprotocol Internet router as well as the OSPF routing protocol.

History

edit

Proteon designed and manufactured of some of the earliest commercial local area network and TCP/IP Internet Router products.[1] Although founded in 1972 by Howard Salwen as communications consulting firm, Proteon became a manufacturer when it produced the first commercial Token Ring network interfaces and media access units in conjunction with MIT.[2] In 1981, it released the 10 Mbit/sec Pronet-10 Token Ring network.[3] and evolved the speeds through 16 MBit/sec, 80 Mbit/sec[4] and 100 Mbit/sec. IBM released a competing Token Ring system in 1984.[5]

In 1986, Proteon released the first commercially available multi-protocol router, the p4200, based on the MIT multi-protocol router, using code developed by Noel Chiappa. Proteon's router products made them one of the key companies producing products to support the growing Internet, among rivals such as Cisco and Wellfleet Communications.[6]

Proteon went public in 1991, issuing 3.1 million shares.[7]

Proteon was renamed and relaunched as OpenROUTE Networks in 1998.[8] OpenRoute Networks merged into Netrix in 1999.[9] The combined company was rebranded as NX Networks[10], which was acquired by NSGDatacom in 2002[11], who formed the Netrix product division to support the acquired product line[12].

References

edit
  1. ^ Carpenter, Brian E. (April 10, 2013). Network Geeks: How They Built The Internet. Springer London. p. 85. ISBN 9781447150251.
  2. ^ Chiappa, J. Noel (April–June 2014). "Early Token Ring Work at MIT". IEEE Annals of the History of Computing. 36 (2): 82–83. Bibcode:2014IAHC...36b..80C. doi:10.1109/MAHC.2014.14. S2CID 30761524.
  3. ^ Pelkey, James. "Entrepreneurial Capitalism and Innovation: A History of Computer Communications 1968-1988". A HISTORY OF COMPUTER COMMUNICATIONS: 1968 -1988. Retrieved 6 April 2021.
  4. ^ "Network World". 2 February 1987. p. 17. Retrieved 4 April 2021.
  5. ^ Sanger, David (9 May 1984). "A LINKING NETWORK BY I.B.M." The New York Times. Retrieved 6 April 2021.
  6. ^ "INTERNET HISTORY OF 1980S". Computer History Museum.
  7. ^ "Equity Issues This Week". The New York Times. 28 May 1991. Retrieved 6 April 2021.
  8. ^ "SECURITIES AND EXCHANGE COMMISSION Form 8-k". Retrieved 3 April 2021.
  9. ^ Dow Jones NewsWires (27 August 1999). "Netrix to Merge With Openroute In Deal Valued at About $114 Million". Retrieved 3 April 2021.
  10. ^ Knight, Jerry (January 10, 2000). "Washington Investing". The Washington Post. Retrieved 18 November 2025.
  11. ^ "NSGdata.com buys Nx Networks out of Bankruptcy". Mirus Capital Advisors. Retrieved 18 November 2025.
  12. ^ "Network Exchange, VoIP, SIP, TDM, WAN and Integrated Access". NSG Datacomm. Retrieved 18 November 2025.
edit

📚 Artikel Terkait di Wikipedia

Proteon Therapeutics

Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri. Proteon was founded by Dr

Raphaël Dubois

bioluminescence and anesthesia. He coined the terms proteon and bioproteon, from the Greek "proteon" for matter and "bios" for life. Bioproteon means "living

Token Ring

development of IBM's Token Ring technology, while early work at MIT led to the Proteon 10 Mbit/s ProNet-10 Token Ring network in 1981 – the same year that workstation

Local area network

.80C. doi:10.1109/MAHC.2014.14. S2CID 30761524. Pelkey, James. "14.18 Proteon in Chapter 14 - Internetworking: Emergence 1985-1988". The History of Computer

List of pharmaceutical companies

Protein Sciences (subsidiary of Sanofi; before 2013– ) Protek (1990– ) Proteon (2001– ) Puma (2010– ) Quantum (2004– ) Quark (1993– ) R-Pharm (2001– )

Epitope binning

Pinkerton; J. Pons (March 2009). "Exploring blocking assays using Octet, ProteOn, and Biacore biosensors". Analytical Biochemistry. 386 (2): 172–180. doi:10

Perrigo

Élan (Acq 2013) Omega Pharma (Acq 2015) Geiss, Destin & Dunn (Acq 2016) Proteon Therapeutics (Acq 2016) Ranir Global Holdings LLC (Acq 2019) HRA Pharma

Proteus in popular culture

Atraxa trilogy by Desmond Ravenstone, the Atraxa Defense Services use "proteon suits" which incorporate nanotechnology to sense the approach of a bullet